Manulife (Manufacturers Life Insurance)’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-259
| Closed | -$97K | – | 3092 |
|
2020
Q4 | $97K | Buy |
259
+35
| +16% | +$13.1K | ﹤0.01% | 2957 |
|
2020
Q3 | $69K | Buy |
+224
| New | +$69K | ﹤0.01% | 2866 |
|
2020
Q2 | – | Sell |
-246
| Closed | -$56K | – | 2879 |
|
2020
Q1 | $56K | Buy |
246
+27
| +12% | +$6.15K | ﹤0.01% | 2718 |
|
2019
Q4 | $116K | Sell |
219
-6
| -3% | -$3.18K | ﹤0.01% | 2763 |
|
2019
Q3 | $99K | Hold |
225
| – | – | ﹤0.01% | 2822 |
|
2019
Q2 | $268K | Sell |
225
-10
| -4% | -$11.9K | ﹤0.01% | 2437 |
|
2019
Q1 | $293K | Buy |
235
+17
| +8% | +$21.2K | ﹤0.01% | 2279 |
|
2018
Q4 | $206K | Sell |
218
-14
| -6% | -$13.2K | ﹤0.01% | 2301 |
|
2018
Q3 | $333K | Sell |
232
-26
| -10% | -$37.3K | ﹤0.01% | 2495 |
|
2018
Q2 | $416K | Buy |
258
+248
| +2,480% | +$400K | ﹤0.01% | 2537 |
|
2018
Q1 | $17K | Buy |
10
+1
| +11% | +$1.7K | ﹤0.01% | 3788 |
|
2017
Q4 | $15K | Buy |
9
+1
| +13% | +$1.67K | ﹤0.01% | 3873 |
|
2017
Q3 | $11K | Buy |
+8
| New | +$11K | ﹤0.01% | 3797 |
|
2017
Q2 | – | Sell |
-2
| Closed | -$1K | – | 4393 |
|
2017
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 4044 |
|
2016
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 4191 |
|